European Biotechs Enter the IPO Big League
Genmab's NASDAQ Debut Biggest of 2019
Executive Summary
2019 has seen European biotech companies making waves in the US IPO space. Genmab’s listing was a blockbuster, but many more companies have proven their ability to go public on the NASDAQ.